Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Bergmann

Showing results (191-200 of 254) with videos related to

Pageof 26
Sort By:
European Journal of Heart Failure|December 29, 2018
Adrenomedullin in heart failure: pathophysiology and therapeutic applicationAdriaan A Voors, Daan Kremer, Christopher Geven, et al.
The Journal of Clinical Endocrinology and Metabolism|August 13, 2024
Deficiency of Peptidylglycine-alpha-amidating Monooxygenase, a Cause of Sarcopenic Diabetes MellitusAlice Giontella, Mikael Åkerlund, Kevin Bronton, et al.
European Journal of Heart Failure|February 5, 2009
Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatientsChristopher Adlbrecht, Martin Hülsmann, Guido Strunk, et al.
European Heart Journal|April 7, 2009
C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL studyAdriaan A Voors, Stephan von Haehling, Stefan D Anker, et al.
Critical Care (London, England)|November 26, 2010
Copeptin and risk stratification in patients with acute dyspneaMihael Potocki, Tobias Breidthardt, Alexandra Mueller, et al.
Journal of Breath Research|August 4, 2017
Strategies for the identification of disease-related patterns of volatile organic compounds: prediction of paratuberculosis in an animal model using random forestsElisa Kasbohm, Sina Fischer, Anne Küntzel, et al.
Journal of the American College of Cardiology|October 18, 2014
Pro-substance p for evaluation of risk in acute myocardial infarctionLeong L Ng, Jatinderpal K Sandhu, Hafid Narayan, et al.
Transplantation Direct|August 11, 2017
Plasma Proenkephalin and Poor Long-Term Outcome in Renal Transplant RecipientsLyanne M Kieneker, Oliver Hartmann, Joachim Struck, et al.
International Journal of Cardiology|December 26, 2009
Midregional pro-A-type natriuretic peptide for the evaluation of exercise intoleranceMicha T Maeder, Martin H Brutsche, Andreas Christ, et al.
Journal of the American College of Cardiology|November 13, 2010
Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillationJ Gustav Smith, Christopher Newton-Cheh, Peter Almgren, et al.
Pageof 26

Showing results (191-200 of 254) with videos related to

Sort By:
Pageof 26
European Journal of Heart Failure|December 29, 2018
Adrenomedullin in heart failure: pathophysiology and therapeutic applicationAdriaan A Voors, Daan Kremer, Christopher Geven, et al.
The Journal of Clinical Endocrinology and Metabolism|August 13, 2024
Deficiency of Peptidylglycine-alpha-amidating Monooxygenase, a Cause of Sarcopenic Diabetes MellitusAlice Giontella, Mikael Åkerlund, Kevin Bronton, et al.
European Journal of Heart Failure|February 5, 2009
Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatientsChristopher Adlbrecht, Martin Hülsmann, Guido Strunk, et al.
European Heart Journal|April 7, 2009
C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL studyAdriaan A Voors, Stephan von Haehling, Stefan D Anker, et al.
Critical Care (London, England)|November 26, 2010
Copeptin and risk stratification in patients with acute dyspneaMihael Potocki, Tobias Breidthardt, Alexandra Mueller, et al.
Journal of Breath Research|August 4, 2017
Strategies for the identification of disease-related patterns of volatile organic compounds: prediction of paratuberculosis in an animal model using random forestsElisa Kasbohm, Sina Fischer, Anne Küntzel, et al.
Journal of the American College of Cardiology|October 18, 2014
Pro-substance p for evaluation of risk in acute myocardial infarctionLeong L Ng, Jatinderpal K Sandhu, Hafid Narayan, et al.
Transplantation Direct|August 11, 2017
Plasma Proenkephalin and Poor Long-Term Outcome in Renal Transplant RecipientsLyanne M Kieneker, Oliver Hartmann, Joachim Struck, et al.
International Journal of Cardiology|December 26, 2009
Midregional pro-A-type natriuretic peptide for the evaluation of exercise intoleranceMicha T Maeder, Martin H Brutsche, Andreas Christ, et al.
Journal of the American College of Cardiology|November 13, 2010
Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillationJ Gustav Smith, Christopher Newton-Cheh, Peter Almgren, et al.
Pageof 26